Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas von Deng, Qing, Han, Guangchun, Puebla-Osorio, Nahum, Ma, Man Chun John, Strati, Paolo, Chasen, Beth, Dai, Enyu, Dang, Minghao, Jain, Neeraj, Yang, Haopeng, Wang, Yuanxin, Zhang, Shaojun, Wang, Ruiping, Chen, Runzhe, Showell, Jordan, Ghosh, Sreejoyee, Patchva, Sridevi, Zhang, Qi, Sun, Ryan, Hagemeister, Frederick, Fayad, Luis, Samaniego, Felipe, Lee, Hans C., Nastoupil, Loretta J., Fowler, Nathan, Eric Davis, R., Westin, Jason, Neelapu, Sattva S., Wang, Linghua, Green, Michael R.

Volltext

FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation von Yan, Jun, Zhao, Qingnan, Gabrusiewicz, Konrad, Kong, Ling-Yuan, Xia, Xueqing, Wang, Jian, Ott, Martina, Xu, Jingda, Davis, R. Eric, Huo, Longfei, Rao, Ganesh, Sun, Shao-Cong, Watowich, Stephanie S., Heimberger, Amy B., Li, Shulin

Volltext

Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition von Ishizawa, Jo, Nakamaru, Kenji, Seki, Takahiko, Tazaki, Koichi, Kojima, Kensuke, Chachad, Dhruv, Zhao, Ran, Heese, Lauren, Ma, Wencai, Ma, Man Chun John, DiNardo, Courtney, Pierce, Sherry, Patel, Keyur P, Tse, Archie, Davis, R Eric, Rao, Arvind, Andreeff, Michael

Volltext

Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality von Ishizawa, Jo, Zarabi, Sarah F., Davis, R. Eric, Halgas, Ondrej, Nii, Takenobu, Jitkova, Yulia, Zhao, Ran, St-Germain, Jonathan, Heese, Lauren E., Egan, Grace, Ruvolo, Vivian R., Barghout, Samir H., Nishida, Yuki, Hurren, Rose, Ma, Wencai, Gronda, Marcela, Link, Todd, Wong, Keith, Mabanglo, Mark, Kojima, Kensuke, Borthakur, Gautam, MacLean, Neil, Ma, Man Chun John, Leber, Andrew B., Minden, Mark D., Houry, Walid, Kantarjian, Hagop, Stogniew, Martin, Raught, Brian, Pai, Emil F., Schimmer, Aaron D., Andreeff, Michael

Volltext

Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myeloma von Zhuang, Junling, Shirazi, Fazal, Singh, Ram Kumar, Kuiatse, Isere, Wang, Hua, Lee, Hans C., Berkova, Zuzana, Berger, Allison, Hyer, Marc, Chattopadhyay, Nibedita, Syed, Sakeena, Shi, Judy Qiuju, Yu, Jie, Shinde, Vaishali, Tirrell, Stephen, Jones, Richard Julian, Wang, Zhiqiang, Davis, R. Eric, Orlowski, Robert Z.

Volltext

Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial von Westin, Jason R, MD, Chu, Fuliang, PhD, Zhang, Min, PhD, Fayad, Luis E, MD, Kwak, Larry W, Prof, Fowler, Nathan, MD, Romaguera, Jorge, Prof, Hagemeister, Fredrick, Prof, Fanale, Michelle, MD, Samaniego, Felipe, MD, Feng, Lei, MS, Baladandayuthapani, Veerabhadran, PhD, Wang, Zhiqiang, PhD, Ma, Wencai, PhD, Gao, Yanli, MS, Wallace, Michael, Prof, Vence, Luis M, PhD, Radvanyi, Laszlo, Prof, Muzzafar, Tariq, MD, Rotem-Yehudar, Rinat, PhD, Davis, R Eric, MD, Neelapu, Sattva S, Dr

Volltext

B-cell Receptor Signaling Regulates Metabolism in Chronic Lymphocytic Leukemia von Vangapandu, Hima V, Havranek, Ondrej, Ayres, Mary L, Kaipparettu, Benny Abraham, Balakrishnan, Kumudha, Wierda, William G, Keating, Michael J, Davis, R Eric, Stellrecht, Christine M, Gandhi, Varsha

Volltext

BETP degradation simultaneously targets acute myelogenous leukemic stem cells and the microenvironment von Piya, Sujan, Mu, Hong, Bhattacharya, Seemana, Lorenzi, Philip L, Davis, R. Eric, McQueen, Teresa, Ruvolo, Vivian, Baran, Natalia, Wang, Zhiqiang, Qian, Yimin, Crews, Craig M, Konopleva, Marina, Ishizawa, Jo, You, M. James, Kantarjian, Hagop, Andreeff, Michael, Borthakur, Gautam

Volltext

Tonic B-cell receptor signaling in diffuse large B-cell lymphoma von Havranek, Ondrej, Xu, Jingda, Köhrer, Stefan, Wang, Zhiqiang, Becker, Lisa, Comer, Justin M., Henderson, Jared, Ma, Wencai, Man Chun Ma, John, Westin, Jason R., Ghosh, Dipanjan, Shinners, Nicholas, Sun, Luhong, Yi, Allen F., Karri, Anusha R., Burger, Jan A., Zal, Tomasz, Davis, R.Eric

Volltext

Inhibition of translation initiation factor eIF4a inactivates heat shock factor 1 (HSF1) and exerts anti-leukemia activity in AML von Nishida, Yuki, Zhao, Ran, Heese, Lauren E., Akiyama, Hiroki, Patel, Shreya, Jaeger, Alex M., Jacamo, Rodrigo O., Kojima, Kensuke, Ma, Man Chun John, Ruvolo, Vivian R., Chachad, Dhruv, Devine, William, Lindquist, Susan, Davis, R. Eric, Porco, John A., Whitesell, Luke, Andreeff, Michael, Ishizawa, Jo

Volltext

Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial von Fowler, Nathan H, Dr, Davis, R Eric, MD, Rawal, Seema, PhD, Nastoupil, Loretta, MD, Hagemeister, Fredrick B, Prof, McLaughlin, Peter, Prof, Kwak, Larry W, Prof, Romaguera, Jorge E, Prof, Fanale, Michelle A, MD, Fayad, Luis E, MD, Westin, Jason R, MD, Shah, Jatin, MD, Orlowski, Robert Z, Prof, Wang, Michael, Prof, Turturro, Francesco, Prof, Oki, Yasuhiro, MD, Claret, Linda C, RN, Feng, Lei, MS, Baladandayuthapani, Veerabhadran, PhD, Muzzafar, Tariq, MD, Tsai, Kenneth Y, MD, Samaniego, Felipe, MD, Neelapu, Sattva S, MD

Volltext

Targeting the NOTCH1-MYC-CD44 axis in leukemia-initiating cells in T-ALL von Piya, Sujan, Yang, Yaling, Bhattacharya, Seemana, Sharma, Priyanka, Ma, Huaxian, Mu, Hong, He, Hua, Ruvolo, Vivian, Baran, Natalia, Davis, R. Eric, Jain, Abhinav K., Konopleava, Marina, Kantarjian, Hagop, Andreeff, Michael, You, M. James, Borthakur, Gautam

Volltext

Prognostic impact and targeting of CRM1 in acute myeloid leukemia von Kojima, Kensuke, Kornblau, Steven M., Ruvolo, Vivian, Dilip, Archana, Duvvuri, Seshagiri, Davis, R. Eric, Zhang, Min, Wang, Zhiqiang, Coombes, Kevin R., Zhang, Nianxiang, Qiu, Yi Hua, Burks, Jared K., Kantarjian, Hagop, Shacham, Sharon, Kauffman, Michael, Andreeff, Michael

Volltext

HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes von Mbofung, Rina M., McKenzie, Jodi A., Malu, Shruti, Zhang, Min, Peng, Weiyi, Liu, Chengwen, Kuiatse, Isere, Tieu, Trang, Williams, Leila, Devi, Seram, Ashkin, Emily, Xu, Chunyu, Huang, Lu, Zhang, Minying, Talukder, Amjad H., Tripathi, Satyendra C., Khong, Hiep, Satani, Nikunj, Muller, Florian L., Roszik, Jason, Heffernan, Timothy, Allison, James P., Lizee, Gregory, Hanash, Sam M., Proia, David, Amaria, Rodabe, Davis, R. Eric, Hwu, Patrick

Volltext

ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies von Ishizawa, Jo, Kojima, Kensuke, Chachad, Dhruv, Ruvolo, Peter, Ruvolo, Vivian, Jacamo, Rodrigo O, Borthakur, Gautam, Mu, Hong, Zeng, Zhihong, Tabe, Yoko, Allen, Joshua E, Wang, Zhiqiang, Ma, Wencai, Lee, Hans C, Orlowski, Robert, Sarbassov, Dos D, Lorenzi, Philip L, Huang, Xuelin, Neelapu, Sattva S, McDonnell, Timothy, Miranda, Roberto N, Wang, Michael, Kantarjian, Hagop, Konopleva, Marina, Davis, R Eric, Andreeff, Michael

Volltext

The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma von Latha, Khatri, Yan, Jun, Yang, Yuhui, Gressot, Loyola V, Kong, Ling-Yuan, Manyam, Ganiraju, Ezhilarasan, Ravesanker, Wang, Qianghu, Sulman, Erik P, Eric Davis, R, Huang, Suyun, Fuller, Gregory N, Rao, Arvind, Heimberger, Amy B, Li, Shulin, Rao, Ganesh

Volltext

Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma von Lenz, Georg, Davis, R. Eric, Ngo, Vu N, Lam, Lloyd, George, Thaddeus C, Wright, George W, Dave, Sandeep S, Zhao, Hong, Xu, Weihong, Rosenwald, Andreas, Ott, German, Muller-Hermelink, Hans Konrad, Gascoyne, Randy D, Connors, Joseph M, Rimsza, Lisa M, Campo, Elias, Jaffe, Elaine S, Delabie, Jan, Smeland, Erlend B, Fisher, Richard I, Chan, Wing C, Staudt, Louis M

Volltext

Targeting Unc51-like Autophagy Activating Kinase 1 (ULK1) Overcomes Adaptive Drug Resistance in Acute Myelogenous Leukemia von Bhattacharya, Seemana, Piya, Sujan, Ma, Huaxian, Sharma, Priyanka, Zhang, Qi, Baran, Natalia, Ruvolo, Vivian R, McQueen, Teresa, Davis, R Eric, Pourebrahim, Rasoul, Konopleva, Marina, Kantarjian, Hagop, Cosford, Nicholas D P, Andreeff, Michael, Borthakur, Gautam

Volltext

Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells von Ruvolo, Peter P., Ruvolo, Vivian R., Benton, Christopher B., AlRawi, Ahmed, Burks, Jared K., Schober, Wendy, Rolke, James, Tidmarsh, George, Hail, Numsen, Eric Davis, R., Andreeff, Michael

Volltext

Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma von Kuhn, Deborah J., Berkova, Zuzana, Jones, Richard J., Woessner, Richard, Bjorklund, Chad C., Ma, Wencai, Davis, R. Eric, Lin, Pei, Wang, Hua, Madden, Timothy L., Wei, Caimiao, Baladandayuthapani, Veerabhadran, Wang, Michael, Thomas, Sheeba K., Shah, Jatin J., Weber, Donna M., Orlowski, Robert Z.

Volltext